Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
134 hedge funds and large institutions have $1.07B invested in Axonics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 29 reducing their positions, and 13 closing their positions.
190% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $4.29M
146% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 13
107% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 29
81% more capital invested
Capital invested by funds: $595M → $1.07B (+$480M)
17% more funds holding
Funds holding: 115 → 134 (+19)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$51.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$50.8M |
| 3 |
BAMCO Inc
New York
|
+$33.6M |
| 4 |
BlackRock
New York
|
+$31.7M |
| 5 |
Axa
Paris,
France
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$13.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.5M |
| 3 |
BC
Blackcrane Capital
Bellevue,
Washington
|
-$11.1M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$10.9M |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$10.6M |
AXNX Hedge Fund Activity: Q2 2020 in Review
134 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2020, worth a combined $1.07B — up 81% from $595M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new AXNX positions and 13 closed out — a net gain of 19 holders — while 60 added to existing stakes and 29 trimmed.
The largest buyer was Credit Suisse, adding an estimated $51.8M. The largest seller was Deerfield Management, cutting an estimated $13.3M.
- 134 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2020, up from 115 in Q1 2020.
- Funds reported $1.07B of Axonics, Inc. Common Stock stock for Q2 2020, up 81% quarter-over-quarter.
- 32 funds opened new Axonics, Inc. Common Stock positions in Q2 2020 and 13 closed out, a net change of +19 holders.
- The largest Axonics, Inc. Common Stock buyer in Q2 2020 was Credit Suisse, an estimated $51.8M added.
- The largest Axonics, Inc. Common Stock seller in Q2 2020 was Deerfield Management, an estimated $13.3M sold.
Based on aggregated 13F filings for Q2 2020.